$CELU has out-licensed its regenerative biomaterials portfolio to focus on placental-derived cell therapies. Watch clinical progress and financing: the company

BWB News TV • 2026-11-07 19:01 UTC • By Billy Odell Tucker-Robinson

$CELU has out-licensed its regenerative biomaterials portfolio to focus on placental-derived cell therapies. Watch clinical progress and financing: the company carries a going-concern warning. #biotech

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly